跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brusatol
首页
药物
Brusatol
Brusatol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of brusatol
申请人: UNIV KUNMING MEDICAL
优先权: 2020
CN
Application of brusatol in preparation of anti-NSCLC medicine
申请人: FIRST AFFILIATED HOSPITAL WENZHOU MEDICAL UNIV
优先权: 2022
CN
Method for extracting and purifying brusatol from degreased brucea javanica
申请人: UNIV SHENYANG PHARMACEUTICAL
优先权: 2024
CN
Application of brusatol in preparation of anti-gastric cancer drugs
申请人: DONGGUAN TRADITIONAL CHINESE MEDICINE HOSPITAL
优先权: 2023
CN
Use of brusatol in preparation of drugs for resisting tumor angiogenesis
申请人: UNIV NANTONG
优先权: 2015
CN
Application of brusatol to preparation of medicine for treating cerebral arterial thrombosis
申请人: UNIV NANTONG
优先权: 2021
CN
Application of brusatol in preparing medicament for preventing or/and treating inflammatory diseases
申请人: UNIV CHONGQING
优先权: 2020
CN
Brusatol在制备抗辐射损伤药物中的应用
申请人: 中国人民解放军军事科学院军事医学研究院
优先权: 2022
CN
药物
反馈